Effect of Collaboration between a Community Pharmacist and Physical Therapist on Patients with COPD

Patients with chronic obstructive pulmonary disease (COPD) have difficulty inhaling bronchodilator medication due to dyspnea. We investigated whether collaboration between community pharmacists and physical therapists at a respiratory clinic (COLLAB) that provides breathing exercises and inhalation...

Full description

Saved in:
Bibliographic Details
Published inJapanese Journal of Pharmaceutical Health Care and Sciences Vol. 48; no. 12; pp. 551 - 561
Main Authors Yuya Uragami, Yuki Mizobuchi, Mao Seki, Yasufumi Yamaji, Naomi Iihara
Format Journal Article
LanguageJapanese
Published Japanese Society of Pharmaceutical Health Care and Sciences 10.12.2022
Online AccessGet full text

Cover

Loading…
More Information
Summary:Patients with chronic obstructive pulmonary disease (COPD) have difficulty inhaling bronchodilator medication due to dyspnea. We investigated whether collaboration between community pharmacists and physical therapists at a respiratory clinic (COLLAB) that provides breathing exercises and inhalation instructions to COPD patients resulted in improved breathing techniques and respiratory indices. Indices including the breathing technique scores of exhalation, inhalation, inspiratory length, and breath hold (poor 0, good 8); forced expiratory volume in one second (FEV1); COPD assessment test (CAT) score (good 0, poor 40); and six-minute walk test (6MWT) were measured at 0 and 3 months after COLLAB. Thirty-nine patients participated in the study. The median breathing technique score improved significantly in patients with stages I and II COPD (0-month 6.0 vs 3-month 8.0, P<0.001) and patients with stages III and IV COPD (0-month 3.0 vs 3-month 7.0, P<0.001). The median 6MWT increased to a greater extent in patients with stages I and II COPD and improved the breathing techniques score (4-8 points) more than in patients with a slightly improved score (0-3 points) (48 m vs 0 m, P=0.005). Patients with stages III and IV COPD also had a greater increase in the median FEV1 (0.02 L vs -0.10 L, P=0.013) and decrease in the median CAT score (-3.0 vs 1.0, P=0.024). COLLAB improved the breathing technique scores, with patients achieving significant improvement in techniques having improved clinical indices. Therefore, COLLAB is important to achieve the full effect of inhalation medication in COPD patients.
ISSN:1346-342X
1882-1499